Porton Pharmaceutical Chemicals GmbH

Enabling the Public's Early Access to Good Medicines
#adc; #atmp; #cdmo; #cdmoadc; #cdmohpapi; #cdmosmallmoleculeadc; #crdmodrugdiscoverydrugsubstancedrugproduct; #drugproductcdmo; #global; #oligonucleotides; #peptides; #porton; #smallmolecules;
View Advert in full

Welcome

...to Biotech Outsourcing Strategies Basel 2025

Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. BOS is an event where business gets done and where you can be confident of high quality interactions with potential business partners. You will receive a warm welcome from the Bio2Business team in the fine City of Basel!

BOS Basel 2025's scope is primarily development stage CMC outsourcing for both Small Molecules and Biologics, as well as covering Novel Therapeutic Entities.

BOS Basel 2025 will include a vibrant Exhibition showcasing expertise and capabilities from the CRO and CMO community, click here to view the BOS Basel 2025 Exhibition. To help onboard our Sponsors, please see our Sponsor Onboarding Checklist. In addition, sponsors can refer to a summary of the Exhibition Logistics.

The BOS Events story began in 2006 with our 1st event hosted in Sheffield, UK. Our event format has been refined over the years and now consists of 4 key components; Programme; Partnering; Exhibition and Informal Networking. Please contact the Bio2Business team and we will be delighted to expand on our approach for each of these key ingredients!

New to BOS: Pre-event Workshops, 10th June 2025

Satellite Event Image

More Details / Register

ADC Outsourcing,Technology Transfer,and CDMO-Client Relationship

June 10th, 9am, Hyperion Hotel, Basel

This day has been designed for professionals working in biopharma outsourcing to improve their understanding about the processes involved in outsourced Antibody Drug Conjugates (ADCs).

The workshop will cover technical aspects such as the sourcing of the foundations of ADCs – antibodies, linkers and payload, as well as the conjugation process and other downstream processes that would be common to producing non-ADC drug products.

Those attending will gain invaluable ‘hands-on’ experience of the issues faced in an ADC outsourcing project and how to improve your own company’s processes and performance.
The workshop will be facilitated by highly experienced moderators from big pharma, biotech and CDMOs :

Featured Company

RIC biologics

RIC is a privately-owned European center of excellence for analytical solutions and has been supporting industries and government agencies in various markets for over 35 years. Founded by Professor Pat Sandra in 1986 and currently led...
View profile